Literature DB >> 20166436

Development and validation of a sensitive LC-MS method for the determination of promethazine hydrochloride in human plasma and urine.

Ping Liu1, Sun Liang, Ben-Jie Wang, Rui-Chen Guo.   

Abstract

We developed and validated a sensitive and low sample volume liquid chromatographic-mass spectrometric (LC-MS) method for determination of Promethazine hydrochloride in human plasma (0.5 ml) or urine (0.1 ml). The lower limit of quantification in human plasma and urine was 1.00 ng/ml. The inter- and intra-day precisions (CV %) in both plasma and urine were lower than 10%, the mean method accuracies and recoveries from spiked plasma samples at three concentrations were more than 97%. The developed method was successfully applied to determine Promethazine hydrochloride in human plasma and urine, and proved suitable to clinical pharmacokinetic study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20166436     DOI: 10.1007/BF03191171

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  16 in total

Review 1.  Pharmacokinetic optimisation of antiemetic therapy.

Authors:  M Campbell; D N Bateman
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

2.  The spectrofluorimetric determination of phenothiazine drugs in blood serum.

Authors:  S L Tompsett
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1968

3.  Use of promethazine to hasten adaptation to provocative motion.

Authors:  J R Lackner; A Graybiel
Journal:  J Clin Pharmacol       Date:  1994-06       Impact factor: 3.126

4.  Maternal blood pressure response to the intravenous administration of pethidine-promethazine during labor.

Authors:  M Ron; M Menashe; D Hochner-Celnikier; Z Palti
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1984-09       Impact factor: 2.435

5.  Bioequivalence and pharmacokinetic profile of promethazine hydrochloride suppositories in humans.

Authors:  S Stavchansky; J E Wallace; R Geary; G Hecht; C A Robb; P Wu
Journal:  J Pharm Sci       Date:  1987-06       Impact factor: 3.534

6.  Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine.

Authors:  P Tarkkila; K Törn; M Tuominen; L Lindgren
Journal:  Acta Anaesthesiol Scand       Date:  1995-10       Impact factor: 2.105

7.  Bioequivalency and dose proportionality of three tableted promethazine products.

Authors:  R Zaman; I L Honigberg; G E Francisco; J A Kotzan; J T Stewart; W J Brown; V P Shah; F R Pelsor
Journal:  Biopharm Drug Dispos       Date:  1986 May-Jun       Impact factor: 1.627

8.  Morphine and promethazine as intravenous premedicants.

Authors:  J T Conner; J W Bellville; R Wender; S Wapner; F J Dorey; R L Katz
Journal:  Anesth Analg       Date:  1977 Nov-Dec       Impact factor: 5.108

9.  Determination of promethazine in serum by liquid chromatography.

Authors:  J E Wallace; E L Shimek; S C Harris; S Stavchansky
Journal:  Clin Chem       Date:  1981-02       Impact factor: 8.327

10.  Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine.

Authors:  E R Scherl; J F Wilson
Journal:  Headache       Date:  1995-05       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.